Corteva (NYSE:CTVA) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Corteva (NYSE:CTVA) issued its quarterly earnings results on Thursday. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.04, Briefing.com reports. Corteva had a return on equity of 10.18% and a net margin of 5.66%. The firm had revenue of $2.46 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period last year, the company earned ($0.23) EPS. The firm’s quarterly revenue was down 8.7% on a year-over-year basis.

Here are the key takeaways from Corteva’s conference call:

• Management reaffirmed its 2026 outlook: net sales of about $10.4 billion (up 3%) and operating EBITDA of about $2.8 billion (up 10%), with a roughly 27% EBITDA margin. Executives said year-to-date execution and expected fourth-quarter performance support those targets.
• Third-quarter net sales were $938 million, down 1%, and operating EBITDA was a $269 million loss, down 33% year over year. The company attributed weaker volumes to weather, shipment timing, and its Brazil soybean shift to licensing, while also citing elevated freight and energy-related costs.
• The company crossed into a net out-licensing position and expects about $60 million of net royalty income for 2026. Brazil soybean licensing is expected to shift revenue into the fourth quarter, but management said the model has roughly three times the margins of its prior branded-seed business.
• For 2027–2029, management reiterated targets of 3%–4% annual sales growth and 7%–8% annual EBITDA growth, with a roughly 30% EBITDA margin by 2029. The framework also targets about 60% average free-cash-flow conversion and approximately $1 billion in annual share repurchases, excluding significant M&A.
• Management pointed to longer-term growth opportunities from 12 developing technology platforms, a planned 2027 hybrid-wheat launch, and expanded corn licensing. It cautioned that corn licensing growth is currently constrained by supply, with the triple-stack opportunity expected to contribute more meaningfully in 2028–2029.

Corteva Trading Down 23.7%

CTVA traded down $2.88 on Thursday, reaching $9.26. 64,898,067 shares of the company’s stock were exchanged, compared to its average volume of 8,288,330. The company’s 50 day moving average is $40.43 and its 200-day moving average is $70.20. The company has a market cap of $6.18 billion, a price-to-earnings ratio of 6.13, a PEG ratio of 1.70 and a beta of 0.58. Corteva has a twelve month low of $9.14 and a twelve month high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52.

Corteva Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Tuesday, December 1st will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Tuesday, December 1st. This is a decrease from Corteva’s previous quarterly dividend of $0.18. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Trending Headlines about Corteva

Here are a few of the latest headlines about CTVA:

• Positive Sentiment: Corteva said growth in new-product sales and operational improvements helped cushion broader market pressure in the third quarter. Corteva third-quarter results and outlook
• Neutral Sentiment: Investors bought substantially more CTVA call options than usual. That may signal bullish positioning, but options activity alone does not establish the market’s direction.
• Negative Sentiment: Coverage characterized the quarter as disappointing, citing sales and earnings pressure. While one report showed adjusted EPS of $0.06 versus a $0.02 estimate, the weaker business outlook appears to have outweighed that figure. Zacks coverage of Corteva’s third-quarter results

Wall Street Analyst Weigh In

CTVA has been the topic of several recent analyst reports. Deutsche Bank reiterated a “buy” rating and set a $101.00 price objective on shares of Corteva in a report on Monday, August 3rd. JPMorgan Chase & Co. upgraded shares of Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 target price for the company in a report on Tuesday, October 6th. Oppenheimer set a $17.00 price target on shares of Corteva in a research report on Monday, October 5th. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Finally, New Street Research set a $17.00 price target on shares of Corteva in a research note on Monday, October 5th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Corteva has a consensus rating of “Moderate Buy” and a consensus target price of $56.91.

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.